Allocations
This extract from Preqin’s Quarterly Update: Private Equity, Q1 2015 focuses on global private equity-backed buyout deals, featuring the latest available data.
The number of private equity-backed buyout deals recorded globally in Q1 2015 fell by 20 per cent from 958 in Q4 2014 to 770 in the first quarter of 2015, consistent with a trend that has seen a dip in the number of deals in the first quarter in every year since 2008 (Fig 1). However, the aggregate value rose by 14 per cent from USD85 billion in Q4 2014 to USD97 billion in Q1 2015, the highest
Sobera Capital has acquired assets from Polytechnos Venture Fund II in a secondary direct transaction.
The assets include shares in Nanotron Ltd. (wireless technologies), Panoratio Holdings Inc. (software) as well as Capella Inc, the parent company of ArraVasc Ltd. (medtech).
Sobera Capital is a Berlin based independent secondary direct investor with a focus on venture capital and small-cap funds and assets in T.I.M.E.S, healthcare and selected other industries.
The Michigan Angel Fund (MAF) has closed its second fund (MAF II) with USD2.05 million. MAF II will make its first investment this spring, and plans to make eight to 10 total investments within the next two years.
"There's no doubt that MAF plays an important role in our entrepreneurial economy. Angel investors are a key element to the success of the diversification and growth of the technology startup community in Michigan," says Skip Simms, MAF managing director. "Angel investors provide entrepreneurs the fuel they need to succeed, not just with their investment but with their connections and guidance."
With
Private equity investor Anchor Equity Partners and investment firm KKR are to acquire a controlling stake in South Korean mobile commerce company Ticket Monster (TMON) from Groupon.
Anchor and KKR, in conjunction with TMON’s management, will jointly acquire a controlling stake in TMON and will inject new capital into the company to help fund its future growth opportunities. Anchor and KKR will hold equal stakes in the company. Some of the world’s largest pension, sovereign wealth funds and institutional investors, including the Canada Pension Plan Investment Board and Pavilion Capital, will also be participating as investors in this transaction. Groupon, which
Middle East Venture Partners (MEVP) has held the first close of Middle East Venture Fund II (MEVF II) at USD15 million. The fund will invest in the region's tech and mobile businesses.
MEVFII is MEVP's fourth fund and succeeds its USD70 million Impact Fund that was launched last year for investments in Lebanon's ICT sector. The fund will aim to close in second quarter 2015 with US$30 million to invest. Middle East Venture Fund II is already operational and has approved four investments:
• YouGotAGift.com: The first of its kind online marketplace specialising in digital gift cards in the Middle
Peer-to-peer lender Assetz Capital has raised GBP3,179,750 from 731 investors through the Seedrs platform – the second largest campaign hosted by Seedrs to date.
This raise has cemented Seedrs’s position as “crowdfunder to the professionals”, and follows a number of other successful Seedrs fundraising campaigns.
LandBay, the P2P lending platform for buy-to-let property, raised GBP569,044 across several fundraising rounds through Seedrs in late 2013 and 2014. LandBay has since gone on to raise a venture capital round from Omni Partners.
Trillion Fund, a leading environmental and social crowdfunding platform, raised GBP536,800 through Seedrs in December 2014.
CrowdLords, a
WHEB Partners’ Growth Fund 2 and Dr Jan Verdenhalven have acquired 100 per cent of the shares of Dolan GmbH, Kelheim from Lenzing AG and 100% of the shares of European Carbon Fiber GmbH (ECF), Kelheim from Lenzing AG and Kelheim Fibers GmbH.
Dolan and ECF share production facilities in Kelheim and an experienced management team.
“The sale comprises part of Lenzing’s strategy to focus on its core business of man-made cellulose fibers. With WHEB Partners and Dr Jan Verdenhalven, Lenzing succeeded in finding financially strong, industry-oriented new owners in which both companies will be able to develop more effectively
Brabant Development Agency Capital (BOM Capital) has chosen Investran, SunGard’s integrated private equity solution, to help enhance data and investment transparency across front- and back-office stakeholders and processes.
BOM Capital invests risk capital in start-up, growing and innovative companies in Brabant through long-term equity capital and fund-to-fund investments. BOM Capital will use SunGard’s Investran accounting, deal flow, relationship management, data exchange, and analytics and reporting capabilities to help increase process and operational efficiencies across its finance, compliance, administration, and investment management teams.
“We were seeking a single system to provide data transparency of investments and processes across the portfolio lifecycle
A fund managed by Ares Management’s commercial finance platform is to acquire the asset-based lending portfolio of First Capital Holdings, a commercial finance company that provides asset-based loans and factoring to small and middle-market companies.
First Capital is a portfolio company of HIG Capital. The transaction is expected to close during the second quarter, subject to customary closing conditions. The fund intends to fund the acquisition with a combination of debt and equity.
With this transaction, the Ares Commercial Finance platform, which is part of the firm’s Direct Lending Group, will have approximately USD700 million of loan commitments. The Ares
Contego Medical has completed a USD5.6 million Series B financing round led by Hatteras Venture Partners, an early stage venture firm with a focus on medical devices, biopharmaceuticals, diagnostics and related opportunities in human medicine.
The round also included Mountain Group Partners, Lookout Capital and Medical Mutual.
"Contego Medical's portfolio of angioplasty balloons and stents embodying the Integrated Embolic Protection filter platform represents a breakthrough technology, which we believe will help endovascular interventionalists reduce the risk of stroke and other procedural complications," says Doug Reed MD, General Partner of Hatteras Venture Partners. Doug Reed will be joining Contego Medical as
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
